Mingfang Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mingfang Sun has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Ying Zhou
Division of Rheumatology, Research Institute of Surgery, Daping Hospital, the Army Medical University, Chongqing 400042, China
3 shared publicationsJun Wu
Department of Clinical Laboratory, General Hospital of Yangtze River Shipping, Wuhan, 430010, Hubei Province, China
2 shared publicationsWei Wang
Department of Clinical Laboratory, Longquanyi District of Chengdu Maternity and Child Health Care Hospital, Chengdu, 610100, Sichuan Province, China
2 shared publications
Latest Publications
- Open Access
- 6 November 2018
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 17, 1079-1089
A meta-analysis of the relationship between body mass index and risk of rheumatoid arthritis
The present meta-analysis aimed to evaluate the relationship between body mass index (BMI) and rheumatoid arthritis (RA). A systematic search of the Cochrane, Pubmed, and Embase databases was conducted to identify relevant studies published before September 2017 using terms related to BMI and RA. Fixed or random-effect models were used to estimate the pooled relative risk (RR) with 95 % confidence interval (CI). Subgroup analyses by sex were performed to investigate the association between BMI and RA in male and female subgroups. A total of 14 eligible studies containing 353,948 patients were included in the analysis. The pooled results suggested that the odds ratios (ORs) of RA were 1.08 (95 % CI: 1.00~1.15) for overweight, and 1.32 (95 % CI: 1.11~1.54) for obesity, respectively, suggesting that a higher BMI increases the risk of RA compared to normal weight. Further subgroup analyses showed a positive association between BMI and RA risk but only in females, with a RR of 1.11 (95 % CI: 1.00~1.22) for overweight and 1.40 (95 % CI: 1.24~1.57) for obesity. In conclusion, an increased BMI may lead to a higher risk for RA development. Furthermore, the positive association between BMI and RA risk may be stronger in female populations than in males. However, additional analyses are needed.
- 6 November 2018
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 17, 1079-1089
Open AccessA meta-analysis of the relationship between body mass index and risk of rheumatoid arthritis
The present meta-analysis aimed to evaluate the relationship between body mass index (BMI) and rheumatoid arthritis (RA). A systematic search of the Cochrane, Pubmed, and Embase databases was conducted to identify relevant studies published before September 2017 using terms related to BMI and RA. Fixed or random-effect models were used to estimate the pooled relative risk (RR) with 95 % confidence interval (CI). Subgroup analyses by sex were performed to investigate the association between BMI and RA in male and female subgroups. A total of 14 eligible studies containing 353,948 patients were included in the analysis. The pooled results suggested that the odds ratios (ORs) of RA were 1.08 (95 % CI: 1.00~1.15) for overweight, and 1.32 (95 % CI: 1.11~1.54) for obesity, respectively, suggesting that a higher BMI increases the risk of RA compared to normal weight. Further subgroup analyses showed a positive association between BMI and RA risk but only in females, with a RR of 1.11 (95 % CI: 1.00~1.22) for overweight and 1.40 (95 % CI: 1.24~1.57) for obesity. In conclusion, an increased BMI may lead to a higher risk for RA development. Furthermore, the positive association between BMI and RA risk may be stronger in female populations than in males. However, additional analyses are needed.
- 9 July 2018
- Published by Springer Nature in Genes & Immunity
- Vol. 20 (7) , 606
Correction: Association between interleukin family gene polymorphisms and recurrent aphthous stomatitis risk
The original version of this article omitted the corresponding author Mingfang Sun and the author Ying Zhou from the Division of Rheumatology, Research Institute of Surgery, Daping Hospital, the Army Medical University, Chongqing 400042, China. This has now been corrected in the PDF and HTML versions of the article.
- 9 July 2018
- Published by Springer Nature in Genes & Immunity
- Vol. 20 (7) , 606
Correction: Association between interleukin family gene polymorphisms and recurrent aphthous stomatitis risk
The original version of this article omitted the corresponding author Mingfang Sun and the author Ying Zhou from the Division of Rheumatology, Research Institute of Surgery, Daping Hospital, the Army Medical University, Chongqing 400042, China. This has now been corrected in the PDF and HTML versions of the article.
- 18 March 2018
- Published by Springer Nature in Genes & Immunity
- Vol. 20 (1) , 90-101
Association between interleukin family gene polymorphisms and recurrent aphthous stomatitis risk
The present study was aimed at identifying the association between interleukin family gene polymorphisms and recurrent aphthous stomatitis (RAS) risk using a meta-analysis. We searched the PubMed, web of science, Embase and ScienceDirect-Elsevier databases for research on the interleukin polymorphism and RAS risk. In total 12 studies were included to investigate the relationships between RAS risk and six polymorphisms by calculating pooled odds ratios (ORs) and 95% confidence intervals (CIs). A significant association was found between IL-1β+3954C/T polymorphism and RAS risk. A high risk of RAS was found in RAS patients with the G allele or GG genotype of IL-6−174 polymorphism. Low risk of RAS was found in the C allele of IL-10−592C/A polymorphism under an allele model, but a high risk of RAS was found in IL-10−1082G/A polymorphism. In the subgroup analysis, no correlation was found between the IL-10−1082 polymorphism and RAS risk in the caucasian population with the allele model. In conclusion, an IL-1β+3954C/T polymorphism was determined to be related to susceptibility to RAS, and individuals with the G allele and GG genotype of IL-6−174 or the A allele of IL-10−592 or the G allele of IL-10−1082 appeared to be more vulnerable to developing RAS.
- 18 March 2018
- Published by Springer Nature in Genes & Immunity
- Vol. 20 (1) , 90-101
Association between interleukin family gene polymorphisms and recurrent aphthous stomatitis risk
The present study was aimed at identifying the association between interleukin family gene polymorphisms and recurrent aphthous stomatitis (RAS) risk using a meta-analysis. We searched the PubMed, web of science, Embase and ScienceDirect-Elsevier databases for research on the interleukin polymorphism and RAS risk. In total 12 studies were included to investigate the relationships between RAS risk and six polymorphisms by calculating pooled odds ratios (ORs) and 95% confidence intervals (CIs). A significant association was found between IL-1β+3954C/T polymorphism and RAS risk. A high risk of RAS was found in RAS patients with the G allele or GG genotype of IL-6−174 polymorphism. Low risk of RAS was found in the C allele of IL-10−592C/A polymorphism under an allele model, but a high risk of RAS was found in IL-10−1082G/A polymorphism. In the subgroup analysis, no correlation was found between the IL-10−1082 polymorphism and RAS risk in the caucasian population with the allele model. In conclusion, an IL-1β+3954C/T polymorphism was determined to be related to susceptibility to RAS, and individuals with the G allele and GG genotype of IL-6−174 or the A allele of IL-10−592 or the G allele of IL-10−1082 appeared to be more vulnerable to developing RAS.